All Stories

  1. COVID-19: A Therapeutic Approach Based on Pathophysiological Staging

    Article • The Open Respiratory Medicine Journal, October 2020, Bentham Science Publishers

    pROFESSOR cHRISTIAN C DOMINGO

  2. Late Breaking Abstract - Target populations for type 2 asthma biologics in a real-life population in Spain (BRAVO 2)

    Article • September 2020, European Respiratory Society (ERS)

    pROFESSOR cHRISTIAN C DOMINGO

  3. Late Breaking Abstract - Prevalence, characterization and costs of severe asthma in Spain (BRAVO 1)

    Article • September 2020, European Respiratory Society (ERS)

    pROFESSOR cHRISTIAN C DOMINGO

  4. Clinical and histological impact of omalizumab in oral corticosteroid-dependent severe allergic asthma

    Article • September 2019, European Respiratory Society (ERS)

    pROFESSOR cHRISTIAN C DOMINGO

  5. Late Breaking Abstract - Budget impact of introducing 12SQ HDM SLIT-tablet for house dust mite allergic asthma in Spain

    Article • September 2019, European Respiratory Society (ERS)

    pROFESSOR cHRISTIAN C DOMINGO

  6. A step-down protocol for omalizumab treatment in oral corticosteroid-dependent allergic asthma patients

    Article • British Journal of Clinical Pharmacology, December 2017, Wiley

    pROFESSOR cHRISTIAN C DOMINGO

  7. Pleuropulmonary Toxicity of Another Anti-Parkinson`s Drug: Cabergoline

    Article • The Open Respiratory Medicine Journal, June 2009, Bentham Science Publishers

    pROFESSOR cHRISTIAN C DOMINGO

  8. Design and Analysis of Health Products and Services: An Example at a Specialized COPD Unit

    Article • The Open Respiratory Medicine Journal, August 2008, Bentham Science Publishers

    pROFESSOR cHRISTIAN C DOMINGO

  9. Neglected Respiratory Toxicity Caused by Cancer Therapy

    Article • The Open Respiratory Medicine Journal, December 2007, Bentham Science Publishers

    pROFESSOR cHRISTIAN C DOMINGO, Dr Jorge Roig